VITALNSEVital Chemtech LimitedMinimalNeutral
Announced Tue, 30 Sept · 18:29 IST

Vital Chemtech Limited has informed the Exchange regarding Appointment of Mrs. Sangeeta Vipul Bhatt as Non- Executive Director of the company w.e.f. Jun 14, 2025.

VITAL · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve

Awaiting price reaction for this filing.

AI summary

Vital Chemtech Limited held its 4th AGM on September 27, 2025, via video conferencing, and all 10 resolutions were passed. Key items approved include the audited standalone and consolidated financial statements for FY ending March 31, 2025, the re-appointment of Mrs. Sangeeta Vipul Bhatt (who also changed designation from Whole Time Director to Non-Executive Director), and the appointment of two new Independent Directors: Mr. Ajay Kumar Agrawal and Mr. Vivek Dinesh Nathwani. Shareholders also approved material related party transactions with Vital Chemicals and Vital Synthesis Limited for FY 2025-26, as well as the Vital Employee Stock Option Scheme 2025 and its extension to employees of group/subsidiary companies. Out of 23,951,100 total shares, 17,871,900 votes (about 74.62%) were polled, with all resolutions passing with near-unanimous support — resolutions 1–8 received 100% in favor, while resolutions 9 and 10 (the ESOP items) received 99.58% in favor with 1,200 votes against from public non-institutional shareholders.

Likely market impact

All 10 resolutions passed cleanly, showing strong promoter (who hold ~73% and voted 100% in favor) and institutional support for management's decisions. The new ESOP scheme could lead to some equity dilution in the future, and the related party transactions with group entities are worth monitoring, but the broad shareholder approval signals good governance alignment.